Tag: cancer
-
Biotechs License Solid Tumor Therapy in $2.1B Deal
Biotechnology enterprise Immunomedics Inc. is licensing its enhanced antibody-based treatment for solid tumor cancers to Seattle Genetics, a developer of similar cancer drugs.
-
Alliance to Study Brain Tumor Precision Diagnostics
A group of medical centers and companies, mainly in Philadelphia, is beginning a study of genomic profiling to diagnose brain tumors in adults and children.
-
Grid Computing Harnessed for Childhood Cancer Research
An international consortium is seeking crowdsourced computing power to screen drug candidates for treating a number of cancers affecting children.
-
Immunotherapy Biotech Raises $102 Million in IPO
A biotechnology company developing treatments for solid tumors, harnessing the body’s immune system, for cancer patients most likely to respond is raising $102 million in its initial public stock offering.
-
Simpler Lab Cell Production Techniques Devised
A process is being developed that makes it easier to produce healthy and diseased cells in the lab from human specimens for regenerative medicine and research.
-
Safer Engineered-Cell Cancer Immunotherapy Designed
A biotechnology company designed a new type of engineered T-cell from the immune system that more precisely targets tumors and stays away from healthy cells.
-
FDA Begins Cancer Product Review Center
The U.S. Food and Drug Administration is reorganizing its review of treatments for cancer into a structure that cuts across its traditional bureaucratic lines.
-
Pharma Firms Start Non-Communicable Disease Initiative
A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions.
-
Knowledge Bank Tapped for Precision Cancer Treatments
An international research team devised techniques for analyzing accumulated clinical trial data to help determine precise treatment strategies for people with cancer.
-
MD Anderson, Investment Firm Create Cancer Start-Up
MD Anderson Cancer Center and health care investment enterprise Deerfield Management are starting a new company to develop treatments for cancer that tackle processes feeding tumor growth.